课题基金 / 基金详情

Synthesis and Biochemical Properties of DNA-Intercalators using Natural Products as Lead Compounds.

Synthesis and Biochemical Properties of DNA-Intercalators using Natural Products as Lead Compounds.
使用天然产物作为先导化合物的 DNA 嵌入剂的合成和生化性质。
批准号:
63571011
负责人:
FURUKAWA Hiroshi
金额:
$0.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1989

项目摘要

项目成果

FURUKAWA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of our project was the isolation and structural elucidation of novel chemical constituents from Rutaceous plants, and synthetic and biochemical studies of DNA intercalating agents derived from the natural products as lead compounds.1. The following Rutaceous Plants were investigated.: (1) one genus of Glycosmis. (2) Three genera of Murrays. (3) Fourteen genera of Citrus.2. Novel chemical constituents isolated were classified as follow: (1) Acridones. (2) Binary acridones. (3) Homoacridones. (4) Acridone-Coumarin dimers. (5) Carbazoles. (6) Carbazolequinones. (7) Binary carbazoles. (8) Indoles. (9) Coumarins. (10) Binary coumarins. (11) Flavonoids. (12) Others.3. Five 9-substituted 1,3-dimethoxyaminoacridines were syntheized as DNA intercalating agents.4. Twentyfour 5-methoxy-7-methyl-7H-pyrido[4,3-c]carbazoles were synthesized from "mukonal", one of carbazole alkaloids, as a lead compound.5. The mutagenic activities were found to be enhanced by the location of an amino- alkane side chain on the skeleton in Ames tests of these derivatives.6. Among thirty acridone alkaloids, citrusinine-I and atalaphillinine were found to exhibit potent anti-herpesvirus and anti-malarial activities, respectively.7. Spectrometric analyses (UV and NMR) of synthetic pyridocarbazoles showed the presence of strong stacking interactions between these molecule themselves and all kind of DNA-bases.
期刊论文(59)
专著(0)
科研奖励(0)
会议论文
Chihiro Ito: "New Coumarins from Some Citrus Plants" Chemical Pharmaceutical Bulletin. 36. 3805-3810 (1988)
伊藤千寻:“来自某些柑橘类植物的新香豆素”化学制药通报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroshi Furukawa: "Spectrometric Elucidation of Acrimarines,The First Naturally Occurring Acridone-Coumarin Dimers" Journal of Chemical Society Perkin Transaction I. (1990)
Hiroshi Furukawa:“吖啶酮的光谱解析,第一个天然存在的吖啶酮-香豆素二聚体”化学学会期刊 Perkin Transaction I. (1990)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazumi Takeya: "Triphasic Inotropic Response of Guinea-pig Papillary Muscle to Murrayaquinone-A Isolated from Rutaceae." Europ. J. Pharmacol., 169, 137-145 (1989).
Kazumi Takeya:“豚鼠乳头肌对从芸香科分离的 Murrayaquinone-A 的三相正性肌力反应。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Chihiro Ito: "Structure of Bisosthenon,A Novel Dimeric Coumarin from Citrus Plants." Chem.Pharm.Bull.37. 1957-1959 (1989)
Chihiro Ito:“Bisosthenon 的结构,一种来自柑橘类植物的新型二聚香豆素。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
51
    Development of non vascularized lymph node transfer by regulation of ECM
    • 批准号:
      20K09874
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      FURUKAWA Hiroshi
    • 依托单位:
    Development of an adaptive mechanism to differences in user attributes, situation, and environment for safe and secure pedestrian navigation
    • 批准号:
      17K00436
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2017
    • 负责人:
      FURUKAWA Hiroshi
    • 依托单位:
    The surgical lymphatic regeneration for improving the prognosis of melanoma
    • 批准号:
      15H05001
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.57万
    • 财政年份:
      2015
    • 负责人:
      FURUKAWA Hiroshi
    • 依托单位:
    Elucidation of the genetic factors and the mechanisms of adverse effects by anti-rheumatic drugs.
    国内基金
    海外基金
    自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
    • 批准号:
      JCZRLH202601177
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
    • 批准号:
      2026JJ80500
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      阳帆
    • 依托单位:
    乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
    • 批准号:
      2026JJ81975
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      肖娇
    • 依托单位:
    淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究